AMRN
Amarin Corporation plc
NASDAQ · Healthcare · Biotechnology · IE
$13.63
−0.58%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
-1.9%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 3, 2026 | Fishman Peter L. · officer: SVP, CFO | F-InKind | 155 | $14 |
| Aug 3, 2026 | Fishman Peter L. · officer: SVP, CFO | M-Exempt | 313 | $0.00 |
| Aug 3, 2026 | Fishman Peter L. · officer: SVP, CFO | A-Award | 313 | $0.00 |
| Jul 15, 2026 | Keenan David Paul · officer: EVP, Chief Operating Officer | M-Exempt | 3,688 | $0.00 |
| Jul 15, 2026 | Provoost Jonathan · officer: EVP, Chief Legal Officer | M-Exempt | 3,688 | $0.00 |
| Jul 15, 2026 | Ketchum Steven B · officer: EVP, Chief Scientific Officer | F-InKind | 1,887 | $16 |
| Jul 15, 2026 | Ketchum Steven B · officer: EVP, Chief Scientific Officer | A-Award | 3,688 | $0.00 |
| Jul 15, 2026 | Keenan David Paul · officer: EVP, Chief Operating Officer | F-InKind | 1,926 | $16 |
| Jul 15, 2026 | Fishman Peter L. · officer: SVP, CFO | M-Exempt | 2,447 | $0.00 |
| Jul 15, 2026 | Provoost Jonathan · officer: EVP, Chief Legal Officer | F-InKind | 1,264 | $16 |
| Jul 15, 2026 | Fishman Peter L. · officer: SVP, CFO | F-InKind | 1,206 | $16 |
| Jul 15, 2026 | Keenan David Paul · officer: EVP, Chief Operating Officer | A-Award | 3,688 | $0.00 |
| Jul 15, 2026 | Ketchum Steven B · officer: EVP, Chief Scientific Officer | M-Exempt | 3,688 | $0.00 |
| Jul 15, 2026 | Provoost Jonathan · officer: EVP, Chief Legal Officer | A-Award | 3,688 | $0.00 |
| Jul 15, 2026 | Fishman Peter L. · officer: SVP, CFO | A-Award | 2,447 | $0.00 |
| Jun 30, 2026 | Berg Aaron · officer: President and CEO | M-Exempt | 6,250 | $0.00 |
| Jun 30, 2026 | Berg Aaron · officer: President and CEO | F-InKind | 3,197 | $16 |
| Apr 22, 2026 | Bonfiglio Patrice Eadon · director | F-InKind | 403 | $15 |
| Apr 22, 2026 | Bonfiglio Patrice Eadon · director | M-Exempt | 838 | $0.00 |
| Apr 21, 2026 | O'Connor Oliver · director | F-InKind | 438 | $15 |
| Apr 21, 2026 | Odysseas Kostas D · director | M-Exempt | 838 | $0.00 |
| Apr 21, 2026 | Sullivan Diane E. · director | F-InKind | 403 | $15 |
| Apr 21, 2026 | Horn Keith · director | M-Exempt | 838 | $0.00 |
| Apr 21, 2026 | Odysseas Kostas D · director | F-InKind | 403 | $15 |
| Apr 21, 2026 | Horn Keith · director | F-InKind | 403 | $15 |
| Apr 21, 2026 | O'Connor Oliver · director | M-Exempt | 838 | $0.00 |
| Apr 21, 2026 | Sullivan Diane E. · director | M-Exempt | 838 | $0.00 |
| Apr 21, 2026 | Sterling Louis III · director | M-Exempt | 838 | $0.00 |
| Apr 21, 2026 | Sterling Louis III · director | F-InKind | 403 | $15 |
| Apr 21, 2026 | Cohen Paul · director | F-InKind | 403 | $15 |
Institutional positioning
13F filings over the trailing two quarters
New 29Increased 37Reduced 25Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Sarissa Capital Management LP | Unchanged | 1,673,395 | Aug 14, 2026 |
| SARISSA CAPITAL MANAGEMENT LP | Unchanged | 1,673,395 | May 15, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 720,984 | Aug 13, 2026 |
| ACADIAN ASSET MANAGEMENT LLC | Increased | 636,769 | May 13, 2026 |
| Kynam Capital Management, LP | Increased | 532,982 | Aug 14, 2026 |
| KYNAM CAPITAL MANAGEMENT, LP | Increased | 472,382 | May 15, 2026 |
| MILLENNIUM MANAGEMENT LLC | Increased | 300,536 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 293,172 | May 15, 2026 |
| POINT72 ASSET MANAGEMENT, L.P. | Increased | 240,761 | May 15, 2026 |
| MORGAN STANLEY | Reduced | 223,617 | Aug 13, 2026 |
| Waterfront Wealth Inc. | Increased | 213,949 | Jul 30, 2026 |
| WATERFRONT WEALTH INC. | Increased | 203,338 | Apr 30, 2026 |
| Brooklands Fund Management Ltd | New Position | 177,325 | Aug 11, 2026 |
| EVERSEPT PARTNERS, LP | Reduced | 147,715 | May 15, 2026 |
| Eversept Partners, LP | Reduced | 145,296 | Aug 14, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 3, 2026